1.5 credits
|
Applying New Data to
Refine the Management of
Retinal Venous Occlusion
By:
The goal of this activity is to introduce physicians to the latest clinical trial
results from two phase 3 studies of antivascular endothelial growth factor
(anti-VEGF) in macular edema secondary to CRVO and BRVO. Recently, the
intravitreal dexamethasone implant (Ozurdex, Allergan, Inc) was approved by
the Food and Drug Administration for the treatment of macular edema secondary
to BRVO and CRVO. This recent approval was based on two multicenter,
double-masked, randomized, parallel studies. Study one included 403
patients and study two included 450 patients.
Expires: Monday, February 28, 2011
|
|
1.5 credits
|
Intravitreal Corticosteroids: A Review of Therapeutic and Surgical Applications
By: Articles and discussion featuring course director Timothy G. Murray, MD; and faculty members Julia A. Haller, MD; Allen C. Ho, MD; and Seenu M. Hariprasad, MD.
Jointly sponsored by the Dulaney Foundation and Retina Today. Release date: December 2009. Expiration date: December 2010.
This continuing medical education activity is supported by an unrestricted educational grant from Alcon Laboratories, Inc.
Expires: Friday, December 31, 2010
|
|
|
1.5 credits
|
Clinical Considerations in Low-Tension Glaucoma
By: Featuring: Robert N. Weinreb, MD, L. Jay Katz, MD, Theodore Krupin, MD and Jeffrey Liebmann, MD
Jointly sponsored by the Dulaney Foundation and Glaucoma Today.
Release date: November 2009. Expiration date: November 2010.
This continuing medical education activity is supported by an unrestricted educational grant from Allergan, Inc.
Expires: Tuesday, November 30, 2010
|
|
1.5 credits
|
New and Emerging Treatment Paradigms for Macular Edema in Retinal Vein Occlusion and Diabetic Retinopathy
By: Scott W.Cousins,MD,Moderator
David S. Boyer,MD
Miguel A. Busquets,MD, FACS
Pravin U.Dugel,MD
Jeffrey S. Heier,MD
Michael A. Singer,MD
Jointly sponsored by the Dulaney Foundation and Retina Today.
Release date: October 2009. Expiration date: October 2010.
This continuing medical education activity is supported by an unrestricted educational grant from Allergan, Inc.
Expires: Sunday, October 31, 2010
|
|
|
1 credit
|
Hot Topics in Gluacoma Care: Highlights of a symposium held during the 2009 World Glaucoma Congress
By: Norbert Pfeiffer,MD
Ivan Goldberg,MBBS, FRANZCO,FRACS
Robert D. Fechtner,MD
Christophe Baudouin,MD
Malik Y.Kahook,MD
Jointly sponsored by the Dulaney Foundation and Glaucoma Today.
Release date: October 2009. Expiration date: October 2010.
This continuing medical education activity is supported by an unrestricted educational grant from Alcon Laboratories, Inc.
Expires: Sunday, October 31, 2010
|
|
2 credits
|
Innovations In Combination Therapy For Wet Age-Related Macular Degeneration
By: Featuring: Pravin U. Dugel, MD, Moderator,
Borja Corcóstegui, MD,
Carl C. Awh, MD,
Peter Wiedemann, MD,
Joe O'Sullivan, MD, FRCPI, FFRRCSI,
Tim Jackson, PhD, FRCOphth
Jointly sponsored by the Dulaney Foundation and Retina Today.
Release date: August 2009. Expiration date: August 2010.
This continuing medical education activity is supported by an unrestricted educational grant from Neovista, Inc.
Expires: Thursday, September 30, 2010
|
|
|
1.5 credits
|
Winning the War on Resistance
Current Antimicrobial Considerations in Anterior Segment Surgery
By: Richard L. Lindstrom, MD, Stephen S. Lane MD, Francis S. Mah, MD, Michael Raizman, MD
Jointly sponsored by the Dulaney Foundation and Cataract & Refractive Surgery Today.
Release date: August 2009. Expiration date: August 2010.
This continuing medical education activity is supported by an unrestricted educational grant from Alcon Laboratories, Inc.
Expires: Tuesday, August 31, 2010
|
|
|
|
1 credit
|
NEW THERAPEUTIC TARGETS IN THE MANAGEMENT OF RETINAL VENOUS OCCLUSION (RVO)
By: Featuring: Robert L. Avery, MD; David M. Brown, MD; Peter A. Campochiaro, MD; Allen C. Ho, MD; and Dante J. Pieramici, MD
Jointly sponsored by the Dulaney Foundation and Retina Today.
Release date: June 2009. Expiration date: June 2010.
This continuing medical education activity is supported by an unrestricted educational grant from Genentech, Inc.
Expires: Wednesday, June 30, 2010
|
|
|
